UBS/CALL/ROCHE GS/360.004/0.025/20.12.24 Share Price

Warrant

WZROGU

CH0589942462

Real-time Bid/Ask 06:05:45 23/05/2024 pm IST
0.005 CHF / 0.028 CHF -5.56% Intraday chart for UBS/CALL/ROCHE GS/360.004/0.025/20.12.24
Current year-41.94%

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer UBS
WZROGU
ISINCH0589942462
Date issued 14/01/2021
Strike 360 CHF
Maturity 20/12/2024 (211 Days)
Parity 40 : 1
Emission price 0.39 CHF
Emission volume N/A
Settlement physique
Currency CHF

Technical Indicators

Highest since issue 1.617 CHF
Lowest since issue 0.018 CHF
Delta0.03x
Omega 12.37
Premium54.59x
Gearing353.48x
Moneyness 0.6480
Difference Strike 126.8 CHF
Difference Strike %+35.21%
Spread 0.023 CHF
Spread %82.14%
Theoretical value 0.0165
Implied Volatility 29.19 %
Total Loss Probability 97.91 %
Intrinsic value 0.000000
Present value 0.0165
Break even 360.66 CHF
Theta-0x
Vega0x
Rho0x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
231.9 CHF
Average target price
279.4 CHF
Spread / Average Target
+20.48%
Consensus
  1. Stock Market
  2. Warrants
  3. WZROGU Warrant